Cerus Corporation
CERS
#7719
Rank
A$0.64 B
Marketcap
A$3.22
Share price
-0.88%
Change (1 day)
32.74%
Change (1 year)

Earnings for Cerus Corporation (CERS)

Earnings in 2026 (TTM): A$1.91 Million

According to Cerus Corporation's latest financial reports the company's current earnings are A$0.22 Billion. In 2025 the company made an earning of -A$9.99 Million, an increase over its 2024 earnings that were of -A$17.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cerus Corporation from 1997 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$1.91 M-119.14%
2025 -A$9.99 Million-41.58%
2024 -A$17.1 Million-58.95%
2023 -A$41.64 Million-20.74%
2022 -A$52.53 Million-25.7%
2021 -A$70.69 Million-11.99%
2020 -A$80.32 Million-14%
2019 -A$93.4 Million21.73%
2018 -A$76.73 Million-0.65%
2017 -A$77.23 Million-10.96%
2016 -A$86.74 Million4.24%
2015 -A$83.21 Million50.99%
2014 -A$55.11 Million-10.08%
2013 -A$61.29 Million184.13%
2012 -A$21.58 Million-7.91%
2011 -A$23.43 Million
2009 -A$33.08 Million-24.69%
2008 -A$43.93 Million-25.2%
2007 -A$58.73 Million330.54%
2006 -A$13.64 Million1.49%
2005 -A$13.44 Million-61.02%
2004 -A$34.48 Million
2002 -A$85.29 Million10.02%
2001 -A$77.52 Million34.25%
2000 -A$57.74 Million61.02%
1999 -A$35.86 Million-18.81%
1998 -A$44.17 Million93.08%
1997 -A$22.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
A$5.38 B 305,369.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Utah Medical Products
UTMD
A$18.53 M 951.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
A$0.23 B 12,987.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$23.77 Million-1,448.57%๐Ÿ‡บ๐Ÿ‡ธ USA